Health news
Pfizer and BioNTech announced positive findings from a study evaluating 2 Omicron-adapted COVID-19 vaccine candidates. The phase 2/3 trial assessed the safety, tolerability, and immunogenicity of a booster (fourth) dose of an Omicron-adapted monovalent vaccine…
The Food and Drug Administration (FDA) has approved Breyanzi® (lisocabtagene maraleucel) for the treatment of adult patients with large B-cell lymphoma (LBCL), including diffuse large B-cell lymphoma (DLBCL) not otherwise specified (including DLBCL arising from…
The Food and Drug Administration (FDA) has ordered JUUL Labs Inc to stop selling and distributing its electronic nicotine delivery system (ENDS) in the US. The banned products include the JUUL device and 4 types…
Vi-Jon, LLC is voluntarily recalling 1 lot of CVS Magnesium Citrate Saline Laxative Oral Solution Lemon Flavor, 10 fl oz (296mL) due to microbial contamination with Gluconacetobacter liquefaciens, a Gram-negative bacterium. The affected product lot…
The Food and Drug Administration (FDA) has granted accelerated approval to Tafinlar® (dabrafenib) + Mekinist® (trametinib) for the treatment of individuals 6 years of age and older with unresectable or metastatic solid tumors with BRAF…
The Food and Drug Administration (FDA) has granted Orphan Drug designation to VBI-1901 for the treatment of glioblastoma. Glioblastoma is a rare, aggressive, malignant grade IV brain tumor that develops from the glial cells. VBI-1901…
The Food and Drug Administration (FDA) has approved the supplemental Biologics License Application for Vaxneuvance (pneumococcal 15-valent conjugate vaccine) for the prevention of invasive pneumococcal disease in pediatric patients 6 weeks through 17 years of…
Nalmefene Hydrochloride Injection is now available for the complete or partial reversal of opioid drug effects, including respiratory depression, induced by either natural or synthetic opioids, and in the management of known or suspected opioid…
Topline results were announced from a phase 3 study evaluating eplontersen in patients with hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN). Hereditary ATTR is a severe, progressive and life-threatening disease caused by the abnormal formation and aggregations…
The Food and Drug Administration’s (FDA) Psychopharmacologic Drugs Advisory Committee voted 3 “yes” and 9 “no” on whether the available evidence supports the conclusion that pimavanserin is effective for the treatment of hallucinations and delusions…
© 2005-2021 Top-Meds - All rights reserved. Our website services, content, and products are for informational purposes only. Top-Meds does not provide medical advice, diagnosis, or treatment. | Medical News 2021
| מאפרת כלות artle.co.il |